Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator flaflyersfan, Doubledown22, Stock Barber, vikingzskillz, Valiant, baryoboy
Search This Board:
Last Post: 7/7/2015 5:33:10 PM - Followers: 419 - Board type: Free - Posts Today: 49

MAJOR NEWS HEADLINE ::::::::::::::::::: CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B


About the Company:

EP Global Communications, Inc. is an Advanced Technology Research and Development company for both Medical Devices and Consumer Electronics Devices specializing in Microelectronic Mechanical Systems (MEMS). For more information about the company, please click on the banner above to be directed to the comapny website.

People, Products & Process:
EPGL has assembled an impressive team to propel the company into a bright future and to build shareholder value. Under the leadership of Michael Hayes EPGL underwent debt restructuring, assembly of a new management team, as well as medical and scientific personnel. Mr. Hayes has made it a singular priority to bring aboard only the world’s top professionals in the field of medical sciences to EPGL and thereby build the Company into a major player in the Medical Device Industry over the next several years. He has also committed to prioritizing shareholders and creating significant value for their investment over time. We have seen great evidence of the har work over the last couple years as EPGL has signed Development Agreements with CooperVision, Intel, and AT&T. EPGL is in negotiations to licence technology to CooperVision presently. On April 28th 2015, EPGL disclosed to shareholders that
EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties. Shareholders can expect developments on this in the near future.

One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.

The Company has significant know-how and Intellectual Property in the arena of BioMEMS and has invented new device technologies which include, but are not limited to the following:
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
EPGL develops advanced technololgies and in negotiations currently to license them to medical device companies and consumer electronic companies.

Contract with CooperVision:
EPGL and CooperVision, Inc. (CooperVision) have signed an exclusive Development Agreement for Advanced Ophthalmic and Medical Technologies. CooperVision is a market leader in the manufacturing and marketing of contact lenses. The Cooper Companies recently completed the acquisition of Sauflon Pharmaceuticals Limited for approximately $1.2 Billion Dollars.

CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B Ophthalmic Technologies Discoveries Could Revolutionize the Future of Eye Care

CooperVision, Inc. Asks EP Global Communications, Inc. to Grant Option to License Immediately EPGL Considering its Options in Light of the Early Request

Exclusive Development Agreement Signed with CooperVision, Inc., a Division of The Cooper Companies, Inc. (COO, NYSE)

Contract with Intel:
On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an Initial Agreement. Additional Agreements are now pending. EPGL management believes that a relationship with Intel will be advantageous to shareholders as the two companies have synergistic goals in various fields. Details of further Agreements will be available upon mutual decision of the parties to disclose them publicly.

On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an initial Agreement. Additional Agreements are now pending.

Contract with AT&T: 
A new Development Agreement has been executed between AT&T and EPGL on January 4, 2015. As a result of this agreeement Joint Intellectual Properties are now being developed certain data streaming projects in mind. EPGL continues to create new and innovative technologies with large companies
New** EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties (4/28/15)

EPGL and AT&T Developing Joint Intellectual Properties Companies Sign Development Agreement Resulting in New Inventions in IoT Data Streaming Space

EPGL and AT&T Sign Development Agreement

About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so. As of Start of January 2015 Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares.  Reduction of A/S and O/S is currently ongoing and first evidence of EPGL reducing shares will be shown in upcoming Quartley Report  Q3, 2015
** Press Release **  - Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares Beginning January 2015

** OTC Disclosure ** - Supplemental Information- Retirement of Common Shares by Beneficial Shareholders Commences

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) Worlds Largest Accounting Firm
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restruture in 2012***
Total number of shareholders of record 700 approximate 

The Company leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**

Additional Information :
Letter From PricewaterhouseCoopers (Ian Stokoe) Congratulating EPGL on First  Devlopment Agreement (CooperVision)

Follow EPGL on Twiter @epglMED
Follow EPGL on the WEB at



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
EPGL News: CooperVision, Inc. Seeks Intermediary as EP Global Communications, Inc., Opens Negotiations at $1.1B 03/30/2015 01:11:00 PM
EPGL News: One Bright Light in Energy Sector and Brief Reports on Companies Poised for Growth 01/29/2015 07:00:00 AM
#79762  Sticky Note EPGL Twitter Update 6/16/15 Nice UPDATE... vikingzskillz 06/16/15 10:19:06 PM
#79335  Sticky Note July 29,2013 - Self Powered Contact Lens judypudy 06/05/15 10:31:01 PM
#75988  Sticky Note $EPGL is Leading the GIANTS in BioMems Technology. Doubledown22 03/18/15 01:20:47 PM
#55008  Sticky Note New Investor Q&A H8ster 07/21/14 04:20:33 AM
#80508   Epgl wont ever release a product because they KBing617 07/07/15 06:05:32 PM
#80507   It may be in a companies best interest vikingzskillz 07/07/15 05:33:10 PM
#80506   Again, utility patent applications are "laid open" and Stock Barber 07/07/15 05:30:20 PM
#80505   I would think that they can make a gr8f1 07/07/15 05:15:09 PM
#80504   True. But there is also money potential Badgerland 07/07/15 05:02:25 PM
#80503   Well if that's true oh well I'm sure Flipper10x 07/07/15 04:57:48 PM
#80502   I have honestly never seen a technology deal Stock Barber 07/07/15 04:47:37 PM
#80501   EPGL maybe farther along then any of us judypudy 07/07/15 04:28:11 PM
#80500   How long it takes to gain the fully Badgerland 07/07/15 04:12:55 PM
#80499   I mean realistically this low volume could be Valiant 07/07/15 04:08:34 PM
#80498   It's hard to know what to expect because Valiant 07/07/15 04:05:10 PM
#80497   I don't think there is any problem with gr8f1 07/07/15 04:03:56 PM
#80496   Same here. I don't have a lot of kura 07/07/15 03:49:06 PM
#80495   I don't think anyone should give up on Stentor1 07/07/15 03:44:11 PM
#80494   Also...if EPGL is up 50% over a 2 Valiant 07/07/15 03:39:40 PM
#80493   2-3 years away from a patent. I Valiant 07/07/15 03:38:12 PM
#80492   Huh....that would be good news. The Valiant 07/07/15 03:36:45 PM
#80491   That means we are 2-3 years away? Many kura 07/07/15 03:36:28 PM
#80490   Every time I say "years away", I get Stentor1 07/07/15 03:28:07 PM
#80489   Once it's filed and excepted you can show Flipper10x 07/07/15 03:01:02 PM
#80488   How long do you estimate and why do Valiant 07/07/15 02:58:46 PM
#80487   Thanks. That is what I was Valiant 07/07/15 02:52:06 PM
#80486   It won't take that long Flipper10x 07/07/15 02:51:40 PM
#80485   24 to 36 months... Stock Barber 07/07/15 02:46:28 PM
#80484   Non-Provisional patent filing usually takes 24 months to Valiant 07/07/15 02:42:53 PM
#80483   Agreed but just saying the market will know gman22 07/07/15 02:18:19 PM
#80482   Agreed. A deal would be sweet for gman22 07/07/15 02:15:16 PM
#80481   We are on the cusp of nonprov patent gr8f1 07/07/15 02:00:07 PM
#80480   I will be truly and very pleasantly 'surprised' gr8f1 07/07/15 01:41:20 PM
#80479   I think we get some news on the gman22 07/07/15 01:39:35 PM
#80478   I agree but it's still early and with Flipper10x 07/07/15 01:35:51 PM
#80477   My interpretation is deal is still being negotiated. gman22 07/07/15 01:34:51 PM
#80476   Yes....I think there is accumulation at every level gman22 07/07/15 01:33:26 PM
#80475   I hope deal is announced afterhours one of vikingzskillz 07/07/15 01:07:41 PM
#80474   You might be right, but twit says, news kura 07/07/15 01:03:17 PM
#80473   In my case there is an accumulation lol. franck92 07/07/15 12:10:46 PM
#80472   Maybe all the small 10k buys every hour Flipper10x 07/07/15 12:04:50 PM
#80471   I doubt any deal has happened volume. gman22 07/07/15 11:50:59 AM
#80470   Time will tell that's one thing we will baryoboy 07/07/15 11:05:20 AM
#80469   I will be laughing all the way to gr8f1 07/07/15 10:27:08 AM
#80468   Deal will be announced when they want to vikingzskillz 07/07/15 09:36:33 AM
#80467   Dare I say that this will pop?? CancunCharlie 07/07/15 09:20:09 AM
#80466   Wondering if EPGL could clarify situation with nowy257 07/07/15 01:21:31 AM
#80465   2. Impending; imminent. Scutterflux 07/07/15 01:16:52 AM
#80464   Tic toc tic toc It's just a matter epglholder 07/07/15 12:40:44 AM
#80463   News on negotiations is pending ,well they nowy257 07/07/15 12:29:38 AM
#80462   Today's tweets $EPGL $COO Electronics in Contact Lenses: vikingzskillz 07/07/15 12:16:47 AM
#80461   It will come when it comes, and when vikingzskillz 07/07/15 12:14:42 AM
#80460   Last time they said negotiation on coo is kura 07/07/15 12:07:57 AM
#80459   I hope your right. They certainly have had judypudy 07/06/15 11:17:42 PM